
Core Insights - Rigel Pharmaceuticals, Inc. will report its first quarter 2025 financial results on May 6, 2025, after market close [1] - A live conference call and webcast will follow the announcement at 4:30 p.m. Eastern Time [1] - The company focuses on developing therapies for hematologic disorders and cancer [3] Financial Reporting - The financial results will be discussed in a conference call accessible via domestic and international dialing options [2] - The webcast will be archived for 90 days for replay on the company's website [2] Company Overview - Rigel Pharmaceuticals was founded in 1996 and is based in South San Francisco, California [3] - The company is dedicated to discovering and developing novel therapies to improve patient lives [3]